Concepedia

Tianyu Cai

TC

Statistics

Publications

34

Citations

1.6K

H-Index

24

Active since

2009

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Dana-Farber Cancer Institute

Wannan Medical College

Peking University

AbbVie (United States)

Tianyu Cai is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and pharmacology.

ORCID

Publications per year

2009–2024

34

Publications

34

Blastic Plasmacytoid Dendritic Cell Neoplasm Is Dependent on BCL2 and Sensitive to Venetoclax

Joan Montero, Jason Stephansky, Tianyu Cai et al. · Cancer Discovery · 2016 · 209 citations · Full text

, , +14

Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes

Polina Matre, Juliana Vélez, Rodrigo Jácamo et al. · Oncotarget · 2016 · 190 citations · Full text

, , +12

Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia

Qi Zhang, Bridget Riley‐Gillis, Lina Han et al. · Signal Transduction and Targeted Therapy · 2022 · 181 citations · Full text

, , +17

Exogenous mitochondrial transfer and endogenous mitochondrial fission facilitate AML resistance to OxPhos inhibition

Kaori Saito, Qi Zhang, Haeun Yang et al. · Blood Advances · 2021 · 81 citations · Full text

, , +16

Superior efficacy of cotreatment with BET protein inhibitor and BCL2 or MCL1 inhibitor against AML blast progenitor cells

Warren Fiskus, Tianyu Cai, Courtney D. DiNardo et al. · Blood Cancer Journal · 2019 · 67 citations · Full text

, , +17

1–5 of 34